NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial (vol 391, pg 1174, 2018)

被引：0
|
作者：
Harrison, S. A.
Rinella, M. E.
Abdelmalek, M. F.
机构：
来源：
LANCET | 2018年 / 391卷 / 10126期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E16 / E16
页数：1
相关论文
共 50 条
  • [31] Denifanstat for the treatment of metabolic dysfunction- associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2btrial
    Loomba, Rohit
    Bedossa, Pierre
    Grimmer, Katharine
    Kemble, George
    Martins, Eduardo Bruno
    Mcculloch, William
    O'Farrell, Marie
    Tsai, Wen-Wei
    Cobiella, Jose
    Lawitz, Eric
    Rudraraju, Madhavi
    Harrison, Stephen A.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (12): : 1090 - 1100
  • [32] Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial
    Sitbon, Olivier
    Bosch, Jaume
    Cottreel, Emmanuelle
    Csonka, Denes
    de Groote, Pascal
    Hoeper, Marius M.
    Kim, Nick H.
    Martin, Nicolas
    Savale, Laurent
    Krowka, Michael
    LANCET RESPIRATORY MEDICINE, 2019, 7 (07): : 594 - 604
  • [33] Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial
    Morice, Alyn H.
    McGarvey, Lorcan
    Pavord, Ian D.
    Higgins, Bernard
    Chung, Kian Fan
    Birring, Surinder S.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (07) : 1864 - 1872
  • [34] Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial
    Kirschner, Janbernd
    Schessl, Joachim
    Schara, Ulrike
    Reitter, Bernd
    Stettner, Georg M.
    Hobbiebrunken, Elke
    Wilichowski, Ekkehard
    Bernert, Guenther
    Weiss, Simone
    Stehling, Florian
    Wiegand, Gert
    Mueller-Felber, Wolfgang
    Thiele, Simone
    Grieben, Ulrike
    von der Hagen, Maja
    Luetschg, Juerg
    Schmoor, Claudia
    Ihorst, Gabriele
    Korinthenberg, Rudolf
    LANCET NEUROLOGY, 2010, 9 (11): : 1053 - 1059
  • [35] Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK
    Denison, Fiona C.
    Carruthers, Kathryn F.
    Hudson, Jemma
    McPherson, Gladys
    Chua, Gin Nie
    Peace, Mathilde
    Brewin, Jane
    Hallowell, Nina
    Scotland, Graham
    Lawton, Julia
    Norrie, John
    Norman, Jane E.
    PLOS MEDICINE, 2019, 16 (12)
  • [36] Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial
    Noto, Davide
    Petta, Salvatore
    Giammanco, Antonina
    Spina, Rossella
    Cabibbi, Daniela
    Porcasi, Rossana
    Caldarella, Rosalia
    Ciaccio, Marcello
    Muratore, Roberto
    Cefalu, Angelo B.
    Craxi, Antonio
    Averna, Maurizio
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (05) : 1288 - 1291
  • [37] Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial
    Taher, Ali T.
    Cappellini, Maria Domenica
    Kattamis, Antonis
    Voskaridou, Ersi
    Perrotta, Silverio
    Piga, Antonio G.
    Filosa, Aldo
    Porter, John B.
    Coates, Thomas D.
    Forni, Gian Luca
    Thompson, Alexis A.
    Tartaglione, Immacolata
    Musallam, Khaled M.
    Backstrom, Jay T.
    Esposito, Oriana
    Giuseppi, Ana Carolina
    Kuo, Wen-Ling
    Miteva, Dimana
    Lord-Bessen, Jennifer
    Yucel, Aylin
    Zinger, Tatiana
    Shetty, Jeevan K.
    Viprakasit, Vip
    LANCET HAEMATOLOGY, 2022, 9 (10): : E733 - E744
  • [38] A Multicentric, Double-Blind, Randomized Placebo-Controlled Trial of High Dose Ursodeoxycholic Acid in Patients with Non-Alcoholic Steatohepatitis (NASH)
    Ratziu, Vlad
    De Ledinghen, Victor
    Frederic, Oberti
    Mathurin, Philippe
    Bladou, Claire Wartelle
    Renou, Christophe
    Spenard, Jean
    GASTROENTEROLOGY, 2009, 136 (05) : A846 - A846
  • [39] Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
    Nakamori, Masayuki
    Nakatani, Daisaku
    Sato, Tomoharu
    Hasuike, Yuhei
    Kon, Seiko
    Saito, Toshio
    Nakamura, Harumasa
    Takahashi, Masanori P.
    Hida, Eisuke
    Komaki, Hirofumi
    Matsumura, Tsuyoshi
    Takada, Hiroto
    Mochizuki, Hideki
    ECLINICALMEDICINE, 2024, 67
  • [40] Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial
    Nogueira, Monize Aydar
    Oliveira, Claudia Pinto
    Ferreira Alves, Venancio Avancini
    Stefano, Jose Tadeu
    dos Reis Rodrigues, Livia Samara
    Torrinhas, Raquel Susana
    Cogliati, Bruno
    Barbeiro, Hermes
    Carrilho, Flair Jose
    Waitzberg, Dan Linetzky
    CLINICAL NUTRITION, 2016, 35 (03) : 578 - 586
12345